Scancell Holdings PLC (AIM:SCLP, OTC:SCNLF), which is developing groundbreaking immunotherapies, is set to showcase early promising results from its ModiFY.
Oncternal Therapeutics, Inc (NASDAQ:NASDAQ:ONCT) Q1 2022 Earnings Conference Call May 5, 2022, 5:00 PM ET Company Participants James Breitmeyer – President & Chief Executive Officer.